SEC Form 4 · accession 0001623919-16-000072
EndoChoice Holdings, Inc. · GI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
R Scott Huennekens
Director
Period of report
Apr 29, 2016
Accepted (ET)
May 3, 2016 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623919
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF2,F3 | Apr 29, 2016 | A | 5,462 | $0.00 | A | 55,869 | D | |
| Common stock, par value $0.001 per shareF1 | holding | — | — | — | 26,666 | I | By Saol Capital LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Saol Capital LLC is owned equally by The Huennekens Family Trust dated June 14, 2007 and The Kieran and Mary Ellen Gallahue Revocable Family Trust dated January 24, 2004, as amended, which hold voting and dispositive power with respect thereto. The Huennekens Family Trust dated June 14, 2007 is owned directly and equally by the reporting person and Deborah Legome Huennekens. The Kieran and Mary Ellen Gallahue Revocable Trust is owned directly and equally by Kieran Thomas Gallahue and Mary Ellen Gallahue. By virtue of the relationships described in this footnote, the entities and individuals described herein may be deemed to beneficially own the shares owned by Saol Capital.
- F2These shares represent an award of restricted stock units that will be settled in common stock upon vesting. The restricted stock units will vest on April 29, 2017, which is one year from the grant date.
- F3The total direct shares shown includes 49,103 time-vesting restricted stock and/or unit award shares.